| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/14/2023 | 22.88% | DA Davidson | $36.5 → $34 | Upgrades | Neutral → Buy |
| 07/31/2023 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 07/27/2023 | 33.72% | Keefe, Bruyette & Woods | $40 → $37 | Maintains | Outperform |
| 05/01/2023 | 30.1% | Raymond James | $43 → $36 | Maintains | Outperform |
| 04/27/2023 | 40.95% | Piper Sandler | $44 → $39 | Maintains | Overweight |
| 04/27/2023 | 51.79% | Keefe, Bruyette & Woods | $46 → $42 | Maintains | Outperform |
| 04/06/2023 | 55.4% | Raymond James | $45 → $43 | Maintains | Outperform |
| 01/30/2023 | 62.63% | Raymond James | $49 → $45 | Maintains | Market Outperform |
| 01/26/2023 | 62.63% | Piper Sandler | $49 → $45 | Maintains | Overweight |
| 10/31/2022 | 77.09% | Raymond James | $41 → $49 | Maintains | Outperform |
| 10/06/2022 | 48.17% | Raymond James | $43 → $41 | Maintains | Outperform |
| 08/18/2022 | 69.86% | Piper Sandler | $49 → $47 | Upgrades | Neutral → Overweight |
| 08/01/2022 | 51.79% | DA Davidson | $43 → $42 | Downgrades | Buy → Neutral |
| 08/01/2022 | 55.4% | Raymond James | $40 → $43 | Maintains | Outperform |
| 06/23/2022 | 44.56% | Raymond James | $44 → $40 | Maintains | Outperform |
| 05/02/2022 | 59.02% | Raymond James | $49 → $44 | Maintains | Outperform |
| 02/28/2022 | 77.09% | Raymond James | → $49 | Initiates Coverage On | → Outperform |
| 10/12/2021 | 87.93% | Piper Sandler | $49 → $52 | Downgrades | Overweight → Neutral |
| 06/16/2021 | 84.32% | Piper Sandler | $46 → $51 | Upgrades | Neutral → Overweight |
| 07/24/2020 | -9.65% | Piper Sandler | $26 → $25 | Maintains | Neutral |
| 06/19/2020 | — | DA Davidson | Downgrades | Buy → Neutral | |
| 06/18/2020 | -6.04% | Piper Sandler | $32 → $26 | Downgrades | Overweight → Neutral |
| 02/28/2020 | — | DA Davidson | Initiates Coverage On | → Buy | |
| 04/25/2019 | — | Gabelli & Co. | Upgrades | Hold → Buy | |
| 03/25/2019 | — | Piper Sandler | Upgrades | Hold → Buy |
What is the target price for First Bancorp (FBNC)?
The latest price target for First Bancorp (NASDAQ: FBNC) was reported by DA Davidson on September 14, 2023. The analyst firm set a price target for $34.00 expecting FBNC to rise to within 12 months (a possible 22.88% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for First Bancorp (FBNC)?
The latest analyst rating for First Bancorp (NASDAQ: FBNC) was provided by DA Davidson, and First Bancorp upgraded their buy rating.
When is the next analyst rating going to be posted or updated for First Bancorp (FBNC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of First Bancorp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for First Bancorp was filed on September 14, 2023 so you should expect the next rating to be made available sometime around September 14, 2024.
Is the Analyst Rating First Bancorp (FBNC) correct?
While ratings are subjective and will change, the latest First Bancorp (FBNC) rating was a upgraded with a price target of $36.50 to $34.00. The current price First Bancorp (FBNC) is trading at is $27.67, which is out of the analyst's predicted range.